Dr. Barry Dworkin

Initial Omicron data released. Small study from South Africa. Pfizer jumps in with theirs today. Many questions about clinical efficacy remain. Answers will come soon.

Medical Mythbusting Commentary for December 8, 2021

Source:
COVID-19: Antibodies from Pfizer vaccine may be up to 40 times less effective against Omicron, first lab tests suggest

Reference:
Omicron Not Wholly Evading Pfizer COVID Vaccine in Study Gives Scientists Cause for Hope

Related posts:

  1. Preprint study evaluated entire Scottish population and calls into question delaying second Covid vaccine dose up to 12 weeks. After first dose it noted a drop in preventing hospitalization from 84% at 5 weeks to 58% after the 7th. And after 16 weeks?
  2. Retrospective study finds that the flu vaccine has benefits against severe effects of COVID-19. How it does this remains unknown but if true, it will be fascinating and enlightening to figure out how our immune response works in this setting.
  3. Retracted Canadian study that reported 1/1000 risk of myocarditis from mRNA vaccine weaponized by anti-vaccination websites despite data correction by the authors to 1/25,000. Review system worked to uncover error but damage now done.
  4. Moderna CEO should quell their speculative and alarmist comments about Omicron. In times of uncertainty, statements should be calm, measured, humble, and neutral in tone. Answers likely forthcoming in 1-2 wks. Solutions will follow thereafter.